Brain Tumor Epidemiology Consortium (BTEC)
The Brain Tumor Epidemiology Consortium (BTEC) is an open scientific forum organized to foster the development of multi-center, international and inter-disciplinary collaborations that will lead to a better understanding of the etiology, outcomes, and prevention of brain tumors. During the process of attaining this mission, BTEC plans to mentor junior investigators or investigators who are new to brain tumor epidemiologic research.
The Consortium was formed in 2003 after an initial meeting sponsored by the National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics
(DCEG), which is the intramural (in house) research component of the Institute, and the National Institutes of Health's (NIH) Office of Rare Diseases (ORD), and has evolved as a self-directed consortium. Find information about BTEC meeting funding.
The BTEC members have formed several Working Groups (WG) developing ideas for coordinated research focusing on adult gliomas, meningiomas, pediatric brain cancers and family-studies. The BTEC Advisory Board (AB) consists of members selected by vote to represent the BTEC members. The AB meets monthly via teleconference.
BTEC holds annual meetings where BTEC Working Groups meet both individually and jointly to discuss current and future collaborations and scientific findings. The 2011 meeting was hosted by Drs. Margaret Wrensch and Judith Schwartzbaum in San Francisco, CA June 5-7, 2011. It focused on gene-environment interaction studies. The next BTEC meeting will be held in Montpellier, France. More details will be shared when available. Learn more about BTEC annual meetings.
BTEC welcomes new investigators to join the consortium. Investigators are encouraged to contact consortium members if they would be interested in conducting additional analyses of existing consortium data. Find more information about BTEC membership.
NCI Contacts
- Preetha Rajaraman, Ph.D., Radiation Epidemiology Branch (REB), Division of Cancer Epidemiology and Genetics (DCEG)
- Daniela Seminara, Ph.D., Epidemiology and Genomics Research Program (EGRP), Division of Cancer Control and Population Sciences (DCCPS), NCI
